Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:47:42.800Z.
Calculation as of: 2026-10-06T19:47:42.800Z.
Quote observation: 2026-10-06T19:45:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cc1b6a3b00dabe5b261e15a58cf0fecaa0dcd4715ed4b38f5f86d2c12a5f1f47
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$1.02M
PS Ratio
10.48
TTM Avg
20733.20
3Y Avg
20733.20
5Y Avg
20733.20
Market Cap
$893920.00
PS Ratio
N/A
TTM Avg
48450.87
3Y Avg
43764.18
5Y Avg
43764.18
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.12M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.14M | 0.04 | 0.21 | 0.18 | 0.97 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 10.48 | 20733.20 | 20733.20 | 20733.20 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.32M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | 48450.87 | 43764.18 | 43764.18 |
| Genprex, Inc. (GNPX)vs › | $1.32M | N/A | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.33M | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.35M | 20.90 | 232.09 | 232.09 | 232.09 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
